The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Real-time continuous glucose monitoring (rt-CGM) reduced large-for-gestational-age (LGA) births in women with gestational diabetes.

Topline data were announced from a phase 3 trial evaluating ersodetug in patients aged 3 months to 45 years with congenital hyperinsulinism.

Higher body dissatisfaction was linked to more severe eating disorder, depressive symptoms in monozygotic and dizygotic twin difference analyses. HealthDay News — Body dissatisfaction may causally ...

Sports injuries do not occur more often during menstruation, but those sustained during menstruation have a significantly higher burden.

Withdrawal of tirzepatide treatment in adults with obesity who have achieved initial weight loss is associated with substantial weight regain and a corresponding reversal of the positive ...

Credit: Getty Images Experts highlight how nurse practitioners can use lifestyle medicine and nutrition to reduce chronic disease and improve outcomes. More than half of adults in the United States ...

Second-generation automated insulin delivery systems significantly improve likelihood of achieving optimal HbA1c target and increase treatment satisfaction compared with other insulin delivery ...

In DME, 1 year with faricimab can expand VA in treatment-naïve eyes, maintain vision in those previously treated, and lengthen interval after loading doses. Faricimab demonstrates a rapid capability ...

Youth-onset type 2 diabetes (T2D) can be characterized into reproducible clusters that demonstrate differential response to treatments and risk of complications, but cluster membership does not ...

Among patients with diabetes who require in-center hemodialysis, the use of GLP-1 receptor agonists is associated with a lower risk of developing Alzheimer disease and related dementias compared with ...